Publications

Chairakaki AD, Saridaki MI, Pyrillou K, Mouratis MA, Koltsida O, Walton RP, Bartlett NW, Stavropoulos A, Boon L, Rovina N, Papadopoulos NG, Johnston SL and Andreakos E. Plasmacytoid dendritic cells drive acute exacerbations of asthma. J Allergy Clin Immunol 2017 In Press

Galani IE, Triantafyllia V, Eleminiadou EE, Koltsida O, Stavropoulos A, Manioudaki M, Thanos D, Doyle SE, Kotenko SV, Thanopoulou K, Andreakos E. Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness. Immunity 2017; 46(5):875-890

Andreakos E, Salagianni M, Galani IE and Koltsida O. Interferon-λs: Front line guardians of immunity and homeostasis in the respiratory tract. Front Immunol 2017; 8:1232

Chrysanthopoulou A, Kambas K, Stakos D, Mitroulis I, Mitsios A, Vidali V, Angelidou I, Bochenek M, Arelaki S, Arampatzioglou A, Galani IE, Skendros P, Couladouros EA, Konstantinides S, Andreakos E, Schäfer K, Ritis K. Interferon lambda1/IL-29 and inorganic polyphosphate are novel regulators of neutrophil-driven thromboinflammation. J Pathol 2017; 243(1):111-122

Edwards MR, Saglani S, Schwarze J, Skevaki C, Smith JA, Ainsworth B, Almond M, Andreakos E, et al.; members of the EARIP WP2 working group. Addressing unmet needs in understanding asthma mechanisms: From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators. Eur Respir J. 2017; 49(5), pii: 1602448

Galani IE, Koltsida O, Andreakos E. Type III interferons (IFNs): Emerging Master Regulators of Immunity. Adv Exp Med Biol 2015;850:1-15

Galani IE and Andreakos E. Neutrophils in viral infections: Current concepts and caveats. J Leuk Biol 2015; 98(4):557-64

Makras P, Salagianni M, Revelos K, Anastasilakis AD, Schini M, Tsoli M, Kaltsas G, Andreakos E. Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosis. J Clin Endocrinol Metab 2015;100(2):E282-6

Andreakos E. and Papadopoulos NG. IL-25: the missing link between allergy, viral infection, and asthma? Science Transl Med 2014; 6(256):256fs38

Kotsovilis S, Andreakos E. Therapeutic human monoclonal antibodies in inflammatory diseases. Methods Mol Biol 2014; 1060:37-59.

Litsiou E, Semitekolou M, Galani I, Morianos I, Tsoutsa A, Kara P, Rontogianni D, Bellenis I, Konstantinou M, Potaris K, Andreakos E, Sideras P, Zakynthinos S and Tsoumakidou M. CXCL13 production in B cells via TLR/lymphotoxin receptor signaling is involved in lymphoid neogenesis in COPD. Αm J Respir Crit Care Med 2014; 189(3):370-71

Koltsida O, Karamnov S, Pyrillou K, Vickery T, Tamvakopoulos C, Sideras P, Serhan CN and Andreakos Ε*. Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of experimental asthma. EMBO Mol Med 2013; 5(5):762-75

Sideras P, Apostolou E, Stavropoulos A, Sountoulidis A, Gavriil A, Apostolidou A and Andreakos E. Activin, neutrophils, and inflammation: just coincidence? Semin Immunopathol 2013; 35(4):481-499

Salagianni M, Galani IE, Lundberg AM, Davos CH, Varela A, Gavriil A, Lyytikäinen LP, Lehtimäki T, Sigala F, Folkersen L, Gorgoulis V, Lenglet S, Montecucco F, Mach F, Hedin U, Hansson GK, Monaco C, Andreakos E. Toll-like receptor 7 protects from atherosclerosis by constraining ‘inflammatory’ macrophage activation. Circulation 2012;126(8):952-62

Andreakos E*. Asthma exacerbations: Molecular dichotomy between antiviral and pro-inflammatory responses revealed. EMBO Mol Med 2012;4(12):1231-3

Apostolou E, Stavropoulos A, Sountoulidis A, Xirakia C, Giaglis S, Protopapadakis E, Ritis K, Mentzelopoulos S, Pasternack A, Foster M, Ritvos O, Tzelepis GE, Andreakos E, Sideras P. Activin-A overexpression in the murine lung causes pathology that simulates acute respiratory distress syndrome. Αm J Respir Crit Care Med 2012;185(4):382-91 

Sountoulidis A, Stavropoulos A, Giaglis S, Apostolou E, Monteiro R, Chuva de Sousa Lopes SM, Chen H, Stripp BR, Mummery CL, Andreakos E, Sideras P. Activation of the Canonical Bone Morphogenetic Protein (BMP) Pathway During Lung morphogenesis and Adult Lung Tissue Repair. Plos One 2012;7(8):e41460

Koltsida O, Hausding M, Stavropoulos A, Koch S, Tzelepis G, Übel C, Kotenko SV, Sideras P, Lehr HA, Tepe M, Klucher KM, Doyle SE, Neurath MF, Finotto S and Andreakos E*. IL-28A(IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol Med 2011; 3(6):348-61

Xirakia C, Koltsida O, Thanassopoulou A, Aidinis V, Sideras P, Andreakos E. TLR7-triggered antiviral response in the lung mediates acute and long-lasting suppression of experimental asthma. Am J Respir Crit Care Med 2010;181(11):1207-16.
Andreakos E, Rauchhaus U, Stavropoulos A, Endert G, Wendisch V, Benahmed AS, Giaglis S, Karras J, Lee S, Gaus H, Bennett CF, Williams RO, Sideras P, Panzner S. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis. Arthritis Rheum. 2009;60(4):994-1005

Maratheftis CI, Andreakos E, Moutsopoulos HM, Voulgarelis M (2007). Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes. Clin Cancer Res. 2007;13(4):1154-60